| Abarelix | | For palliative treatment of advanced prostate cancer |
| Aminoglutethimide | | For the suppression of adrenal function in selected patients with Cushing s syndrome, Malignant neoplasm of female breast, Carcinoma in situ of breast |
| Anastrozole | | For treatment of advanced breast cancer. |
| Bicalutamide | | For treatment (together with surgery or LHRH analogue) of advanced prostatic cancer. |
| Estradiol | | For the treatment of urogenital symptoms associated with post-menopausal atrophy of the vagina (such as dryness, burning, pruritus and dyspareunia) and/or the lower urinary tract (urinary urgency and dysuria). |
| Exemestane | | For the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy. |
| Fulvestrant | | For the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy. |
| Goserelin | | Breast cancer; Prostate carcinoma; Endometriosis |
| Goserelin | | Breast cancer; Prostate carcinoma; Endometriosis |
| Medroxyprogesterone | | Contraception |
| Nilutamide | | Used as an add-on therapy following surgical or chemical castration due to prostate cancer |
| Progesterone | | For progesterone supplementation or replacement as part of an Assisted Reproductive Technology (ART) treatment for infertile women with progesterone deficiency and for the treatment of secondary amenorrhea. Also used as a female contraceptive. |
| Tamoxifen | | for the treatment of breast cancer |
| Toremifene | | For the treatment of metastatic breast cancer in postmenopausal women with estrogen receptor-positive or receptor-unknown tumors |
